Search Results - "Turini, M.M."

PRO25 Healthcare Resource Use in Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma: Results from a UK-Based Clinician Questionnaire by Scarisbrick, J., Schmidt, F., Turini, M.M., D'agostino, P., Summers, D., van Hest, N., Evans, J.

Get full text

PRO64 MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA (MF-CTCL) EPIDEMIOLOGY AND TREATMENT PATHWAYS IN FRANCE AND SPAIN: NEW INSIGHTS FOR AN ACCURATE DESCRIPTION by D'Agostino, P., Lezzi, C., Kent, A., Sharp, E., Schmidt, F., Turini, M.M.

Get full text

PRO140 Health-Related Quality of Life Associated with Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma Patients: Determination of Utility Values from a UK-Based Clinician Questionnaire by Scarisbrick, J., Schmidt, F., Turini, M.M., D'agostino, P., Thornton, S., Evans, J., Ader, J., van Hest, N., Brazier, J.E.

Get full text

PCN206 NETUPITANT AND PALONOSETRON (NEPA), IS A COST-EFFECTIVE INTERVENTION FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN SINGAPORE by Lim, S.W., Loh, K.W.J., Boisseau, S., Ho, W.T., Qasuri, M., D'agostino, P., Turini, M.M., Bourhis, F., Eriksson, J., Hadjiat, Y.

Get full text

PCN18 A Budget IMPACT Analysis of Fixed Dose Combination of Netupitant and Palonosetron (NEPA) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Malaysia by Lim, C.S., Raggulan, J., Boisseau, S., Yong, F.L., Qasuri, M., D'agostino, P., Turini, M.M., Bourhis, F., Eriksson, J., Hadjiat, Y.

Get full text